Efficacy and toxicities of concurrent chemoradiation for elderly patients with esophageal cancer

Takashi Uno, Koichi Isobe, Hiroyuki Kawakami, Naoyuki Ueno, Hiroki Kobayashi, Hideaki Shimada, Hisahiro Mastubara, Shinichi Okazumi, Yoshihiro Nabeya, Touru Shiratori, Takenori Ochiai, Tetsuya Kawata, Hisao Ito

研究成果: Article

21 引用 (Scopus)

抜粋

Background: To evaluate the efficacy and toxicity of concurrent chemoradiation in patients with esophageal cancer aged 75 and older. Patients and Methods: Twenty-two elderly patients were treated with concurrent chemoradiation. Seventeen received a combination of cisplatin/carboplatin and 5-fluorouracil, 5 received daily 5-fluorouracil. Total doses of radiotherapy ranged from 50 to 65 Gy. Results: Nineteen out of 22 patients completed the planned chemoradiation. Five in 8 patients (63%) with T1-2 lesion and 1 in 14 patients (7%) with T3-4 lesion achieved complete response (p=0.011). Only 2 patients experienced grade 3 toxicities. Grade 2 or worse hematological toxicities were less frequently observed in patients who received local-field radiotherapy (p=0.006). There was no isolated lymph node recurrence. The median survival time was 9 months. Conclusion: This study showed the potential for chemoradiation in elderly patients. A planning target volume of radiotherapy should include only clinically involved lesions in this setting.

元の言語English
ページ(範囲)2483-2486
ページ数4
ジャーナルAnticancer research
24
発行部数4
出版物ステータスPublished - 2004 7 1

    フィンガープリント

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

これを引用

Uno, T., Isobe, K., Kawakami, H., Ueno, N., Kobayashi, H., Shimada, H., Mastubara, H., Okazumi, S., Nabeya, Y., Shiratori, T., Ochiai, T., Kawata, T., & Ito, H. (2004). Efficacy and toxicities of concurrent chemoradiation for elderly patients with esophageal cancer. Anticancer research, 24(4), 2483-2486.